Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,139.83
+60.97
(+0.75%)
FTSE 250
19,824.16
+222.18
(+1.13%)
AIM
755.28
+2.16
(+0.29%)
GBP/EUR
1.1679
+0.0022
(+0.19%)
GBP/USD
1.2494
-0.0017
(-0.13%)
Bitcoin GBP
50,491.70
+697.46
(+1.40%)
BRANDS
'We sold £1.5m of product sold in first week'
Lyma founder on rise of her wellness company
Anavex Life Sciences Corp. (AVXL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.4400
+0.0500
(+1.47%)
At close: 04:00PM EDT
3.4200
-0.02
(-0.58%)
After hours:
06:38PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
40,334
43,717
37,916
32,984
25,232
Selling general and administrative
11,331
12,039
13,070
9,018
5,857
Total operating expenses
51,665
55,731
50,986
41,948
30,938
Operating income or loss
-51,665
-55,731
-50,986
-41,948
-30,938
Interest expense
-
964
0
0
-
Total other income/expenses net
2,327
2,678
2,419
4,281
4,501
Income before tax
-43,043
-47,498
-47,620
-37,641
-26,258
Income tax expense
112
7
358
268
22.664
Income from continuing operations
-43,155
-47,505
-47,978
-37,909
-26,280
Net income
-43,155
-47,505
-47,978
-37,909
-26,280
Net income available to common shareholders
-43,155
-47,505
-47,978
-37,909
-26,280
Basic EPS
-0.60
-0.60
-0.62
-0.54
-0.45
Diluted EPS
-0.60
-0.60
-0.62
-0.54
-0.45
Basic average shares
79,788
79,788
76,910
69,803
58,195
Diluted average shares
79,788
79,788
76,910
69,803
58,195
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.